A clinical-stage biotechnology company

Focused on developing innovative anti-inflammatory
therapies for the treatment of cardiovascular disease

Free
AGORACOM NEWS FLASH

SURVEY FOR #SMALLCAP INVESTORS

In a market correction, how do you want your companies to handle communications?

Very important. Please participate and retweet, please.

Screen-Shot-2022-05-25-at-11-04-53-AM

 

Discussion Forum: Cardiol Theraputics Inc.
List Message View
Thread Message View
New Message
Message Title
Rating
Author / Date
Icon agoracom Cardiol Therapeutics Announces Year-End 2021 Update on Operations

AGORACOM-BM
Mar 24, 2022 08:30AM
Icon agoracom Cardiol Therapeutics to Participate in Cantor Fitzgerald's Virtual Rare Orphan Disease Summit

AGORACOM-BM
Mar 22, 2022 07:33AM
Icon agoracom Cardiol Therapeutics Appoints Jennifer M. Chao to Its Board of Directors

AGORACOM-BM
Mar 15, 2022 07:30AM
Icon agoracom Cardiol Therapeutics Receives Clearance from the FDA and Regulatory Agencies in Brazil and Mexico for Important Protocol Amendments

AGORACOM-BM
Mar 01, 2022 08:00AM
Icon agoracom Cardiol Therapeutics Appoints Thought Leaders in Cardiovascular Medicine to its Scientific Advisory Board

AGORACOM-AB
Jan 19, 2022 07:27AM
Icon agoracom Media Coverage: Globe says Canaccord's Nash rates Cardiol "buy"

AGORACOM-AB
Dec 06, 2021 09:00AM
Icon agoracom Cardiol Therapeutics Announces Closing of US$50 Million Public Offering

AGORACOM
Nov 05, 2021 09:18AM
Icon agoracom Cardiol Therapeutics Announces Pricing of Public Offering of Units

AGORACOM-AB
Nov 03, 2021 08:36AM
Icon agoracom Cardiol Therapeutics Files Preliminary Prospectus Supplement for Proposed Public Offering of Units

AGORACOM-AB
Nov 02, 2021 04:04PM
Icon agoracom Cardiol Therapeutics Receives Health Canada Approval for Phase II Clinical Trial of CardiolRx(TM) for Acute Myocarditis

AGORACOM-AB
Oct 25, 2021 07:27AM
Icon agoracom Cardiol Therapeutics Expands LANCER, a Phase II/III Trial of CardiolRx(TM), into Brazil, Mexico, and Canada

AGORACOM-AB
Oct 18, 2021 07:27AM
Icon agoracom 52-WEEK HIGH ALERT: Cardiol Therapeutics (CRDL:TSX) (CRDL:NASDAQ) Up 6% On 1.16M Shares

AGORACOM
Sep 27, 2021 04:00PM
Icon agoracom 52-WEEK HIGH ALERT: Cardiol Therapeutics (CRDL:TSX) (CRDL:NASDAQ) Up 10% On 965K Shares

AGORACOM
Sep 16, 2021 04:00PM
Icon agoracom Cardiol Therapeutics to Participate in the 2021 Cantor Virtual Global Healthcare Conference

AGORACOM
Sep 16, 2021 07:27AM
Icon agoracom Cardiol Therapeutics Announces Acceleration of Expiry Date of Warrants Issued on June 4, 2020

AGORACOM-AB
Sep 10, 2021 04:33PM
Icon agoracom AGORACOM Small Cap 60: Cardiol Therapeutics $CRDL - COVID-19 Patients with Prior History of Cardiovascular Disease Most Vulnerable

AGORACOM-AB
Sep 08, 2021 12:37PM
Icon agoracom 52-WEEK HIGH ALERT: Cardiol Therapeutics (CRDL:TSX) (CRDL:NASDAQ) Up 13% On 1.29m Shares

AGORACOM-AB
Sep 07, 2021 04:00PM
Icon agoracom Cardiol Therapeutics Appoints Michael J. Willner to Its Board of Directors

AGORACOM
Sep 07, 2021 07:27AM
Icon agoracom Cardiol Therapeutics Receives FDA Clearance of Investigational New Drug Application for Phase II Clinical Trial of CardiolRx(TM) for Acute Myocarditis

AGORACOM-AB
Aug 24, 2021 07:27AM
Icon agoracom AGORACOM Small Cap 60: Cardiol Therapeutics $CRDL Lists On NASDAQ With FDA Approved Clinical Trials & $50m Raised Last 12 Months

AGORACOM-AB
Aug 20, 2021 02:10PM
New Message